Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Regulatory News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.10
Bid: 2.10
Ask: 2.15
Change: -0.05 (-2.30%)
Spread: 0.05 (2.381%)
Open: 2.22
High: 2.22
Low: 2.10
Prev. Close: 2.175
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Apr 2018 08:24

RNS Number : 5795L
Immupharma PLC
20 April 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Immupharma plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Lanstead Capital LP

City and country of registered office (if applicable)

 

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

17/04/2018

6. Date on which issuer notified (DD/MM/YYYY):

19/04/2018

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

0.00%

0.00%

0.00%

139,467,430

Position of previous notification (if

applicable)

5.01%

0.00%

5.01%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

 

ISIN: GB0033711010

0

0

0.00%

0.00%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

0

0.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

XLON

Date of completion

17/04/2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDBLBLVZFLBBF
Date   Source Headline
6th Apr 20207:00 amRNSIMM live on Investor Meet Company platform 7 April
3rd Apr 20203:55 pmRNSHolding(s) in Company
2nd Apr 20208:26 amRNSHolding(s) in Company
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
30th Mar 20208:02 amRNS£1.5m Subscrip'n to fund R&D pipeline- replacement
30th Mar 20207:00 amRNS£1.5m Subscription to fund R&D pipeline expansion
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:40 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:39 pmRNSPrice Monitoring Extension
4th Mar 20204:35 pmRNSPrice Monitoring Extension
28th Feb 20207:03 amRNSIncanthera plc – Admission to trading on NEX
21st Feb 20204:35 pmRNSPrice Monitoring Extension
17th Feb 20208:00 amRNSIncanthera announces Rule 23 Notice re NEX listing
12th Feb 20204:41 pmRNSSecond Price Monitoring Extn
12th Feb 20204:35 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSUpdate on the Avion Agreement
5th Feb 20204:40 pmRNSSecond Price Monitoring Extn
5th Feb 20204:35 pmRNSPrice Monitoring Extension
7th Jan 20204:40 pmRNSSecond Price Monitoring Extn
7th Jan 20204:35 pmRNSPrice Monitoring Extension
19th Dec 20194:35 pmRNSPrice Monitoring Extension
19th Dec 20197:00 amRNSAdmission today to trading on Euronext Growth
17th Dec 20197:00 amRNSPublication of Information Note (Euronext Growth)
13th Dec 20197:00 amRNSDual Listing on Euronext Growth Brussels
11th Dec 201912:49 pmRNSShare Price Volatility
3rd Dec 20197:00 amRNSIMMUPHARMA TO PRESENT AT BIOTECH SHOWCASET 2020
2nd Dec 20197:00 amRNSTR-1: notification of major holdings
28th Nov 20197:00 amRNSLicence Agreement for Lupuzor with Avion in US
25th Nov 20194:41 pmRNSSecond Price Monitoring Extn
25th Nov 20194:35 pmRNSPrice Monitoring Extension
5th Nov 20194:41 pmRNSSecond Price Monitoring Extn
5th Nov 20194:35 pmRNSPrice Monitoring Extension
7th Oct 201912:07 pmRNSSecond Price Monitoring Extn
7th Oct 201912:02 pmRNSPrice Monitoring Extension
4th Oct 201912:07 pmRNSSecond Price Monitoring Extn
4th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20194:40 pmRNSSecond Price Monitoring Extn
1st Oct 20194:35 pmRNSPrice Monitoring Extension
30th Sep 20197:00 amRNSInterim Results Announcement
18th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Jul 20197:00 amRNSTR-1: notification of major holdings
2nd Jul 20193:33 pmRNSTR-1: notification of major holdings
28th Jun 20197:00 amRNSUpdate on Lupuzor
27th Jun 20191:38 pmRNS2019 Annual General Meeting
26th Jun 20197:00 amRNSSubscription to raise £2.66 million
4th Jun 20197:00 amRNSNotice of AGM and posting of Report & Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.